Long-term follow-up after cyclophosphamide and cyclosporine-A therapy in steroid-dependent and -resistant nephrotic syndrome

Pediatric Nephrology

Volumn 23, Issue 7, 2008, Pages 1085-1092

  Sümegi, Viktéria ^a   Haszon, Ibolya ^a   Bereczki, Csaba ^a   Papp, Ferenc ^a   Túri, Sándor ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Cyclophosphamide; Cyclosporine A; Immunosuppressive therapy; Steroid dependent; Steroid resistant

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; STEROID;

ADOLESCENT; ANOREXIA; ARTICLE; CHILD; CHILD CARE; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG RESPONSE; FEMALE; FOCAL GLOMERULOSCLEROSIS; FOLLOW UP; GINGIVA HYPERPLASIA; HEMODIALYSIS; HIRSUTISM; HUMAN; LONG TERM CARE; MALE; MINIMAL CHANGE GLOMERULONEPHRITIS; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEINURIA; RELAPSE; REMISSION; SINGLE DRUG DOSE; TREMOR;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; CYCLOSPORINE; DRUG RESISTANCE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; NEPHROTIC SYNDROME; PROTEINURIA; RECURRENCE; RETROSPECTIVE STUDIES; STEROIDS; TIME FACTORS; TREATMENT OUTCOME;

EID: 44449137870     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-008-0771-8     Document Type: Article

References (39)

1. Ehrich JH, Brodehl J (1991) Long versus standard prednisolone therapy for initial treatment of idiopathic nephrotic syndrome in children (Arbeitsgemeinschaft für Padiatrische Nephrologie). Eur J Pediatr 150:380-387
2. Abeyagunawardena AS, Dillon MJ, Rees L, van't Hoff W, Trompeter RS (2003) The use of steroid-sparing agents in steroid-sensitive nephrotic syndrome. Pediatr Nephrol 18:919-924
3. Sümegi V, Haszon I, Ivanyi B, Bereczki Cs, Papp F, Turi S (2004) Long-term effects of levamisole treatment in childhood nephrotic syndrome. Pediatr Nephrol 19:1354-1360
4. Report of a workshop by the British Association for Paediatric Nephrology and Research Unit, Royal College of Physicians (1994) Consensus statement on management and audit potential for steroid responsive nephrotic syndrome. Arch Dis Child 71:151-157
5. Bircan Z, Kara B (2003) Intravenous cyclophosphamide is the drug of choice for steroid dependent nephrotic syndrome. Pediatr Int 45:65-67
6. Chisthi AS, Solof JM, Brewer ED, Kale AS (2001) Long-term treatment of focal segmental glomerulosclerosis in children with cyclosporine given as a single daily dose. Am J Kidney Dis 38:754-760
7. Eddy AA, Symons JM (2003) Nephrotic syndrome in childhood. Lancet 362:629-639
8. Zietse R, Derkx FH, Schalekamp MA, Weimar W (1995) Cyclosporine and the glomerular filtration barrier in minimal change disease and membranous nephropathy. Contrib Nephrol 114:6-18
9. Borel JF, Feurer C, Gubler HU, Stahelin H (1994) Biological effects of cyclosporine A: A new antilymphocytic agent. 1976. Agents Actions 43:179-186
10. Abramowicz M, Barnett HL, Edelmann CM Jr, Greifer I, Kobayashi O, Arneil GC, Barron BA, Gordillo-P G, Hallman N, Tiddens HA (1970) Controlled trial of azathioprine in children with nephrotic syndrome. A report for the international study of kidney disease in children. Lancet 1:959-961
11. Hogg RJ, Furth S, Lemley KV, Portman R, Schwartz GJ, Coresh J, Balk E, Lau J, Levin A, Kausz AT, Eknoyan G, Levey AS; National Kidney Foundation's Kidney Disease Outcomes Quality Initiative (2003) National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: Evaluation, classification, and stratification. Pediatrics 111:1416-1421
12. Hamahira K, Iijima K, Tanaka R, Nakamura H, Yoshikawa N (2001) Recovery from cyclosporine-associated arteriolopathy in childhood nephrotic syndrome. Pediatr Nephrol 16:723-727
13. Lijima K, Hamahira K, Tanaka R, Kobayashi A, Nozu K, Nakamura H, Yoshikawa H (2002) Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome. Kidney Int 61:1801-1805
14. McCrory WW, Shibuya M, Lu WH, Lewy JE (1973) Therapeutic and toxic effects observed with different dosage programs of cyclophosphamide in treatment of steroid-responsive but frequently relapsing nephrotic syndrome. J Pediatr 82:614-618
15. Ponticelli C, Edefonti A, Ghio L, Rizzoni G, Rinaldi S, Gusmano R, Lama G, Zacchello G, Confalonieri R, Altieri P, Bettinelli A, Maschio G, Cinotti GA, Fuiano G, Schena FP, Castellani A, Della Casa-Alberighi O (1993) Cyclosporine versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: A multicentre randomized controlled trial. Nephrol Dial Transplant 8:1326-1332
16. Niaudet P (1992) Comparison of cyclosporine and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: A multicentre randomized controlled trial. The French Society of Paediatric Nephrology. Pediatr Nephrol 6:1-3
17. Pena A, Bravo J, Melgosa M, Fernandez C, Meseguer C, Espinosa L, Alonso A, Navarro M (2007) Steroid-resistant nephritic syndrome: Long-term evolution after sequential therapy. Pediatr Nephrol 22:1875-1880
18. Grupe WE, Heymann W (1966) Cytotoxic drugs in steroid-resistant renal disease. Alkylating and antimetabolic agents in the treatment of nephrotic syndrome, lupus nephritis, chronic glomerulonephritis, and purpura nephritis in children. Am J Dis Child 112:448-458
19. Querfeld U, Waldherr R, Scharer K (1985) The significance of focal global sclerosis in idiopathic nephratic nephrotic syndrome. Long-term clinical observations. Acta Paediatr Scand 74:913-919
20. Report of the International Study Group of Kidney Disease in Children (1974) Prospective, controlled trial of cyclophosphamide therapy in children with the nephrotic syndrome. Lancet 2:423-427
21. Geary DF, Farine M, Thorner P, Baumal R (1984) Response to cyclophosphamide in steroid-resistant focal segmental glomerulosclerosis: A reappraisal. Clin Nephrol 22:109-113
22. Arbeitsgemeinschaft für Pädiatrische Nephrologie (1982) Effect of cytotoxic drugs in frequently relapsing nephrotic syndrome with and without steroid dependence. N Engl J Med 306:451-454
23. Williams SA, Makker SP, Ingelfinger JR, Grupe WE (1980) Long-term evaluation of chlorambucil plus prednisone in the idiopathic nephrotic syndrome of childhood. N Engl J Med 302:929-933
24. Arbeitsgemeinschaft für Pädiatrische Nephrologie (1987) Cyclophosphamide treatment of steroid dependent nephrotic syndrome: comparison of eight week with 12 week course. Report of Arbeitsgemeinschaft für Paüdiatrische Nephrologie. Arch Dis Child 62:1102-1106
25. Drummond KN, Hillman DA, Marchessault JH, Feldman W (1968) Cyclophosphamide in the nephrotic syndrome of childhood: Its use in two groups of patients defined by clinical, light microscopic and immunopathologic findings. Can Med Assoc J 98:524-531
26. Moncrieff MW, White RH, Oggs CS, Cameron JS (1969) Cyclophosphamide therapy in the nephrotic syndrome in childhood. Br Med J 1:666-671
27. Rance CP, Arbus GS, Balfe JW (1976) Management of the nephrotic syndrome in children. Pediatr Clin North Am 23:735-750
28. Dundon S, O'Callaghan U, Raftery J (1980) Stability of remission in minimal lesion nephrotic syndrome after treatment with prednisolone and cyclophosphamide. Int J Pediatr Nephrol 1:22-25
29. Griswold WR, Kaufman DB, Smith FG, McIntosh RM (1971) Cyclophosphamide in nephrotic syndrome. Clin Res 19:233
30. Latta K, von Schnakenburg C, Ehrich JH (2001) A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children. Pediatr Nephrol 16:271-282
31. Barratt TM, Soothill JF (1970) Controlled trial of cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood. Lancet 2:479-482
32. Ghose S, Kumar M, Kundu B, Bindal S (1977) Long-term follow up of steroid and cyclophosphamide therapy in nephrosis. Indian Pediatr 14:885-889
33. Grushkin CM, Fine RN, Heuser E, Lieberman E (1970) Cyclophosphamide therapy of idiopathic nephrosis. Calif Med 13:1-5
34. Cattran DC, Appel GB, Hebert LA, Hunsicker LG, Pohl MA, Hoy WE, Maxwell DR, Kunis CL (1999) A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. Kidney Int 56:2220-2226
35. Durkan A, Hodson E, Willis N, Craig J (2003) Non-corticosteroid treatment for nephrotic syndrome in children (Cochrane Review) The Cochrane Library. 1. Oxford, Update Software Ltd
36. Kemper MJ, Kuwertz-Broeking E, Bulla M, Mueller-Wiefel DE, Neuhaus TJ (2004) Recurrence of severe steroid dependency in cyclosporin A-treated childhood idiopathic nephrotic syndrome. Nephrol Dial Transplant 19:1136-1141
37. Ingulli E, Singh A, Baqi N, Ahmad H, Moazami S, Tejani A (1995) Aggressive, long-term cyclosporine therapy for steroid-resistant focal segmental glomerulosclerosis. J Am Soc Nephrol 5:1820-1825
38. Sairam VK, Kaila A, Rajaraman S, Travis LB (2002) Secondary resistance to cyclosporin A in children with nephrotic syndrome. Pediatr Nephrol 17:842-846
39. Waldo FB, Benfield MR, Kohaut EC (1998) Therapy of focal and segmental glomerulosclerosis with methylprednisolone, cyclosporine A, and prednisone. Pediatr Nephrol 12:397-400